Environmental tobacco smoke and its effect on the symptoms and medication in children with asthma

Environmental tobacco smoke (ETS) worsens asthmatic symptoms. We analyzed the relationship between levels of ETS and asthmatic symptoms and medication. We asked parents of 282 asthmatic children about the general condition, smoke exposure and medication. Patients were classified into three groups: n...

Full description

Saved in:
Bibliographic Details
Published in:International journal of environmental health research 2009-04, Vol.19 (2), p.97-108
Main Authors: Yamasaki, Akira, Hanaki, Keichi, Tomita, Katsuyuki, Watanabe, Masanari, Hasagawa, Yasuyuki, Okazaki, Ryota, Igishi, Tadashi, Horimukai, Kenta, Fukutani, Kouji, Sugimoto, Yuji, Yamamoto, Mitsunobu, Kato, Kazuhiro, Ikeda, Toshikazu, Konishi, Tatsuya, Tokuyasu, Hirokazu, Yajima, Hiroki, Sejima, Hitoshi, Isobe, Takeshi, Shimizu, Eiji, San-in Asthma Research Group
Format: Article
Language:English
Subjects:
Anti-Asthmatic Agents - therapeutic use
Asthma - complications
Asthma - drug therapy
Asthma - etiology
Child
exposure
Female
Humans
Japan
Male
Public Policy
questionnaire
respiratory
Tobacco Smoke Pollution - adverse effects
Tobacco Smoke Pollution - prevention & control
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Environmental tobacco smoke (ETS) worsens asthmatic symptoms. We analyzed the relationship between levels of ETS and asthmatic symptoms and medication. We asked parents of 282 asthmatic children about the general condition, smoke exposure and medication. Patients were classified into three groups: no-ETS (no smoking), mild-ETS (smoking in the house but not in the same room as patient), and heavy-ETS (smoking in the same room as patient). We classified 116 children in no-ETS group, 124 children in mild-ETS group and 42 children in heavy-ETS group. The symptoms were worst and prevalence of leukotriene receptor antagonist and long-acting β 2 -agonist use were highest in heavy-ETS group. However, there was no statistical difference between no-ETS and mild-ETS groups in prevalence of anti-asthmatic drug use and symptoms. We conclude that a smoking ban in rooms used by asthmatic children is an easy way to reduce ETS, asthmatic symptoms and the use of anti-asthmatic drugs.
ISSN:0960-3123
1369-1619
DOI:10.1080/09603120802392884